What's breaking now, across thousands of outlets.
[Capital FM] Nairobi -- More than half of Kenyans living with metabolic disease do not know they have the disease, while the national caseload is expected to double by 2050, a gap clinicians meeting in Nairobi on Saturday described as a central challenge in the country's response to metabolic disease.
We haven't written up this one. AllAfrica Health has the full story — the link below goes straight to it.
Two companies that have spent decades trying to develop cell therapies for diabetes are set to merge, with the aim of working together to take on a market also being pursued by Vertex and CRISPR ...
BCB-276 is designed to treat diffuse intrinsic pontine glioma (DIPG) by targeting B7-H3, an immune checkpoint protein encoded by the CD276 gene that has been shown to be involved in tumor progression…
Survival rates for childhood cancer now exceed 80%—but this also means more children are living with the long-term emotional and psychosocial impacts of cancer.
A massive review of psychological research reveals that feeling a sense of purpose is strongly linked to lower levels of depression.
A Seattle biotech trying to flip the script on CAR-T cell therapies — making them akin to small molecules for brain tumors — has put together a megaround with the hopes of becoming a commercial-stage…
At least 1,360 doctors leave Israel since 2023 in healthcare brain drain Submitted by Alex MacDonald on Tue, 09/08/2026 - 11:12 Researchers recorded 416 departures in 2023, 530 in 2024, and an initial…
